DISEASE INDICATIONS: Risk of cardiovascular events, Hypercholesterolemia
MANUFACTURER: Amgen Inc.
USAGE: Subcutaneous
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Health Canada
Pharmaceuticals and Medical Devices Agency (PMDA)
Repatha is a subcutaneous injection used to lower LDL cholesterol levels in adults with primary hyperlipidemia or mixed dyslipidemia and in individuals with clinical atherosclerotic cardiovascular disease who require additional LDL cholesterol reduction. It binds to and inhibits PCSK9, promoting the clearance of LDL cholesterol from the bloodstream.
